1,951 Shares in Agilent Technologies, Inc. $A Bought by Allegiance Financial Group Advisory Services LLC

Key Points

• Allegiance Financial Group Advisory Services LLC purchased 1,951 shares of Agilent Technologies, valued at approximately $230,000, indicating growing institutional interest in the company.
• Agilent Technologies reported quarterly earnings of $1.37 per share, meeting analyst expectations, with revenue up 10.1% year-over-year to $1.74 billion.
• The company announced a quarterly dividend of $0.248 to be paid on October 22, with a yield of 0.7% and a dividend payout ratio of 23.24%.

Allegiance Financial Group Advisory Services LLC bought a new position in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 1,951 shares of the medical research company's stock, valued at approximately $230,000.

Several other hedge funds also recently bought and sold shares of A. Brighton Jones LLC boosted its holdings in shares of Agilent Technologies by 6.1% during the 4th quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock valued at $626,000 after purchasing an additional 270 shares during the last quarter. Merit Financial Group LLC boosted its holdings in shares of Agilent Technologies by 56.3% during the 1st quarter. Merit Financial Group LLC now owns 4,348 shares of the medical research company's stock valued at $509,000 after purchasing an additional 1,567 shares during the last quarter. Capital Investment Advisors LLC boosted its holdings in shares of Agilent Technologies by 42.3% during the 1st quarter. Capital Investment Advisors LLC now owns 2,809 shares of the medical research company's stock valued at $329,000 after purchasing an additional 835 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of Agilent Technologies by 34.6% during the 1st quarter. GAMMA Investing LLC now owns 5,362 shares of the medical research company's stock valued at $627,000 after purchasing an additional 1,379 shares during the last quarter. Finally, Fiduciary Financial Group LLC bought a new position in shares of Agilent Technologies during the 1st quarter valued at about $318,000.

Agilent Technologies Stock Up 1.6%

Shares of NYSE A opened at $140.81 on Thursday. The firm's 50-day moving average price is $124.07 and its 200-day moving average price is $116.81. The company has a current ratio of 2.25, a quick ratio of 1.71 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $39.92 billion, a price-to-earnings ratio of 33.05, a P/E/G ratio of 4.52 and a beta of 1.26. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts' consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The company had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the prior year, the company posted $1.32 EPS. The firm's revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Investors of record on Tuesday, September 30th will be given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies's dividend payout ratio is 23.24%.

Analyst Upgrades and Downgrades

Several research firms have commented on A. Rothschild & Co Redburn began coverage on shares of Agilent Technologies in a report on Wednesday. They set a "buy" rating and a $165.00 price objective for the company. Evercore ISI increased their price objective on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an "in-line" rating in a report on Tuesday. Weiss Ratings reissued a "hold (c)" rating on shares of Agilent Technologies in a report on Wednesday. Wall Street Zen upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Friday, October 3rd. Finally, Barclays upped their target price on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an "equal weight" rating in a research report on Thursday, October 2nd. Eight analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, Agilent Technologies presently has a consensus rating of "Moderate Buy" and an average price target of $147.92.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.